GlassScriptPhysician profile
Jose A Martel
NPI 1124053061
$106,767.46
in general payments reported to CMS, 2019-2025
34 companies · $17K in 2025
The $17K reported for 2025 was more than what 87% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27K · 2020: $8,396 · 2021: $21K · 2022: $7,204 · 2023: $16K · 2024: $10K · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $22K · Food and Beverage: $16K · Travel and Lodging: $4,979.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $22,484.00 |
| Food and Beverage | $15,954.12 |
| Travel and Lodging | $4,978.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $55,174.55 | 2019-2025 | Ensite, Tacticath Ablation Catheter, Sensor Enabled, Ensite Precision |
| Medtronic, INC. | $13,456.77 | 2021-2025 | Micra, Cobalt Dr Mri Surescan, Aurora Ev-Icd Mri Surescan |
| Philips North America LLC | $13,092.27 | 2020-2024 | (Ck4) Mcot |
| Boehringer Ingelheim Pharmaceuticals, INC. | $9,922.61 | 2019-2024 | Jardiance |
| Medtronic Vascular, INC. | $4,834.32 | 2019-2020 | |
| Boston Scientific Corporation | $4,537.48 | 2019-2025 | Watchman Flx, Rhythmia Mapping System, Farapulse |
| Cardiva Medical, INC. | $2,538.50 | 2020-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f, Savvywire |
| Atricure, INC. | $550.73 | 2022-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Impulse Dynamics (USA) INC. | $359.11 | 2023-2024 | Optimizer, Optimizer |
| Terumo Medical Corporation | $350.00 | 2019 | |
| Biotronik INC. | $316.47 | 2019-2020 | |
| Cardiofocus, INC. | $303.56 | 2020-2022 | |
| Pfizer INC. | $210.70 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $184.29 | 2019-2023 | Xarelto |
| Biosense Webster, INC. | $133.53 | 2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $110.42 | 2023-2024 | Onpattro |
| E.R. Squibb & Sons, L.L.C. | $99.44 | 2022-2025 | Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $85.98 | 2019-2024 | Lifevest |
| Cms Imaging, INC. | $74.60 | 2023 | |
| Novartis Pharmaceuticals Corporation | $57.14 | 2020-2022 | |
| Ge Healthcare | $57.05 | 2019-2020 | |
| Kiniksa Pharmaceuticals, LTD. | $50.26 | 2021-2023 | Arcalyst |
| Amgen INC. | $39.03 | 2019 | |
| Sanofi-Aventis U.S. LLC | $34.92 | 2019-2023 | |
| Bridgebio Pharma, INC. | $29.98 | 2025 | Attruby |
| Scpharmaceuticals INC. | $25.59 | 2025 | |
| Becton, Dickinson and Company | $21.34 | 2025 | Hemosphere |
| Kiniksa Pharmaceuticals International, Plc | $20.97 | 2024 | Arcalyst |
| Amarin Pharma, INC. | $17.64 | 2019 | |
| Esperion Therapeutics, INC. | $17.41 | 2021 | |
| Kestra Medical Technology Services, INC. | $16.96 | 2025 | Assure Wcd |
| Actelion Pharmaceuticals US, INC. | $15.19 | 2019 | |
| Lilly USA, LLC | $14.60 | 2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $14.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Martel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.